Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Processa Pharma Q2 EPS $(1.01) Beats $(1.02) Estimate

Author: Benzinga Newsdesk | August 28, 2024 08:11am

Processa Pharma (NASDAQ:PCSA) reported quarterly losses of $(1.01) per share which beat the analyst consensus estimate of $(1.02) by 0.98 percent. This is a 49.5 percent increase over losses of $(2.00) per share from the same period last year.

Posted In: PCSA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist